SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Angeline Oi-Shan Lo, Grace Lai-Hung Wong, Current developments in nucleoside/nucleotide analogues for hepatitis B, Expert Review of Gastroenterology & Hepatology, 2014, 1

    CrossRef

  2. 2
    Cho I Lee, So Young Kwon, Jeong Han Kim, Won Hyeok Choe, Chang Hong Lee, Eileen L. Yoon, Jong Eun Yeon, Kwan Soo Byun, Yun Soo Kim, Ju Hyun Kim, Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure, Gut and Liver, 2014, 8, 1, 64

    CrossRef

  3. 3
    Fumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, Norio Akuta, Hitomi Sezaki, Tasuku Hara, Yusuke Kawamura, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Rie Mineta, Hiromitsu Kumada, Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine, Journal of Gastroenterology, 2014, 49, 6, 1094

    CrossRef

  4. 4
    Timothy M. Block, Robert Gish, Haitao Guo, Anand Mehta, Andrea Cuconati, W. Thomas London, Ju-Tao Guo, Chronic hepatitis B: What should be the goal for new therapies?, Antiviral Research, 2013, 98, 1, 27

    CrossRef

  5. 5
    Dae Hun Kwon, In Hee Kim, Bum Su Choung, Dae Seon Ahn, Sun Ho Yoo, Sang Bae Park, Seok Lee, Seong Hun Kim, Sang Wook Kim, Yong Jin Im, Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response, Gut and Liver, 2013, 7, 6, 712

    CrossRef

  6. 6
    Cheng-Yuan Peng, Tsung-Cheng Hsieh, Tsai-Yuan Hsieh, Kuo-Chih Tseng, Chih-Lin Lin, Tung-Hung Su, Tai-Chung Tseng, Hans Hsienhong Lin, Chia-Chi Wang, Jia-Horng Kao, HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients, Journal of the Formosan Medical Association, 2013,

    CrossRef

  7. 7
    Hyung Joon Yim, Seong Gyu Hwang, Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade, Clinical and Molecular Hepatology, 2013, 19, 3, 195

    CrossRef

  8. 8
    Seng Gee Lim, Guan Huei Lee, Kieron Lim, Poh Seng Tan, Resistance is no Longer a Problem with Entecavir and Tenofovir, Current Hepatitis Reports, 2013, 12, 2, 96

    CrossRef

  9. 9
    Benjamin Yip, Kevin Chaung, Carrie R. Wong, Huy N. Trinh, Huy A. Nguyen, Aijaz Ahmed, Ramsey Cheung, Mindie H. Nguyen, Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders, Digestive Diseases and Sciences, 2012, 57, 11, 3011

    CrossRef